QA: Concert Pharmaceuticals INC in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001367920_2020_Concert_Pharmaceuticals_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001367920, Concert Pharmaceuticals INC

  xvar xval
0 AssetsCurrent 116,855,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 7,753,000
3 remainder_Assets 12,863,000
4 LiabilitiesCurrent 17,268,000
5 LiabilitiesNoncurrent 18,746,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 19,690,163
9 ResearchAndDevelopmentExpense 62,074,053
10 remainder_Expenses 140,347
11 remainder_Revenues 5,330,561
12 remainder_NetIncome 618,300
13 remainder_ComprehensiveNetIncome 173,096
  yvar yval
0 Assets 137,471,000
1 Liabilities 36,014,000
2 Expenses 81,904,563
3 Revenues 5,330,561
4 StockholdersEquity 101,457,000
5 NetIncome -75,955,702
6 ComprehensiveNetIncome -75,869,154
7 BaseVar 130,755,760
8 EconomicCapitalRatiobeforeLimitedLiability 1.68
9 EconomicCapitalRatio 2.80

Edgar->Model Mapping

Feature Distribution

Change over Time